Crescent Biopharma (CBIO) Enterprise Value (2013 - 2026)
Crescent Biopharma (CBIO) reported Enterprise Value of -$189.2 million for Q1 2026, down 743.39% year-over-year from $29.4 million in Q1 2025, and up 11.27% quarter-over-quarter from -$213.2 million in Q4 2025.
Crescent Biopharma (CBIO) Enterprise Value (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of Enterprise Value data on file, last reported at -$189.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$189.2 million, down 743.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$189.2 million (down 743.39% YoY), and the FY2025 annual result was -$213.2 million, down 513.22% from the prior year.
- Enterprise Value advanced to -$189.2 million in Q1 2026 per CBIO's latest filing, from -$213.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$14.4 million in Q3 2024 and troughed at -$213.2 million in Q4 2025.
- A 5-year average of -$69.5 million and a median of -$50.5 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 70.85% in 2024, then sank 825.45% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$47.9 million in 2022, then advanced by 12.7% to -$41.8 million in 2023, then rose by 16.81% to -$34.8 million in 2024, then tumbled by 513.22% to -$213.2 million in 2025, then advanced by 11.27% to -$189.2 million in 2026.
- Business Quant data shows CBIO's Enterprise Value at -$189.2 million in Q1 2026, -$213.2 million in Q4 2025, and -$133.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | -189.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -189.16 Mn |
| Dec 31, 2025 | -213.19 Mn |
| Sep 30, 2025 | -133.27 Mn |
| Mar 31, 2025 | -22.43 Mn |
| Dec 31, 2024 | -34.77 Mn |
| Sep 30, 2024 | -14.40 Mn |
| Jun 30, 2024 | -22.40 Mn |
| Mar 31, 2024 | -31.28 Mn |
| Dec 31, 2023 | -41.79 Mn |
| Sep 30, 2023 | -49.41 Mn |
| Jun 30, 2023 | -58.04 Mn |
| Mar 31, 2023 | -65.00 Mn |
| Dec 31, 2022 | -47.87 Mn |
| Sep 30, 2022 | -51.60 Mn |
| Jun 30, 2022 | -60.20 Mn |
| Mar 31, 2022 | -76.52 Mn |
| Dec 31, 2021 | -90.25 Mn |
| Sep 30, 2021 | -101.92 Mn |
| Jun 30, 2021 | -118.85 Mn |
| Mar 31, 2021 | -132.47 Mn |